© 2008 BioRéalités Home Site Map Légal and credits Contact Us
BioRéalités is developing new approaches for the diagnosis and treatment of human colorectal cancer. Our compagny is currently working on the development of a new generation of selective monoclonal antibodies, directed against a novel and innovative colon cancer target, which has been validated in vitro and in vivo through a series of “proof of concept” studies.
BioRéalités is building on a large internal expertise, as well as on strong partnerships with both academic and industrial actors in the field of oncology. Our main R&D projects have received financial support from French institutional bodies such as the Agency for Innovation (Oseo), the National Cancer Institute (INCa) and the National Research Agency (ANR).
BioRéalités is located in Montpellier (France), near the “Arnaud de Villeneuve” campus, which regoups three internationally renowned research institutes.
A new therapeutic approach for cancer
Fund raising
July 2010 - BioRéalités raises 1.3 M€ and moves on with its R&D program.
The company just finalized a new fund raising round again with private investors and Business Angels ...
